Ncardia has developed a process for producing induced pluripotent stem cells (IPSC) and produces cardiac muscle cells or cardiac myocytes. Induced pluripotecy is the 'reprogramming' of a differentiated cell in a stem cell by reactivating the expression of the genes associated with the embryonic stage.
